Overview
Deadline: 21-Oct-2026 Pfizer is inviting eligible organizations to submit proposals for independent medical education projects focused on metastatic castration-resistant prostate cancer (mCRPC). Individual projects can receive between $75,000 and $250,000, supporting initiatives that improve healthcare professionals’ understanding of emerging treatment options, new mechanisms of disease, and innov
Full job description
Deadline: 21-Oct-2026 Pfizer is inviting eligible organizations to submit proposals for independent medical education projects focused on metastatic castration-resistant prostate cancer (mCRPC). Individual projects can receive between $75,000 and $250,000, supporting initiatives that improve healthcare professionals’ understanding of emerging treatment options, new mechanisms of disease, and innovative therapeutic approaches. About the Pfizer mCRPC Medical Education... [Read More] The post CFAs: New Mechanisms and Emerging Treatment Options in Metastatic Castration-Resistant Prostate Cancer first appeared on fundsforNGOs .
Tips for this job
Practical JobOpportunity guidance. These tips do not replace official rules or create new eligibility requirements.
- Tailor the CV and application to the responsibilities and required skills stated on the official employer page.
- Use concrete evidence of relevant work, projects and measurable results rather than generic claims.
- Confirm location, work authorization, remote restrictions and sponsorship terms before applying.
- Apply through the original employer or official recruitment destination shown on this page.
JobOpportunity is the discovery and verification layer. Confirm eligibility, dates, salary/funding and application instructions on the original source before submitting anything.
Apply through JobOpportunity →